Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort data☆
Y. Di Filippo, Stéphane Dalle, Laurent Mortier, O. Dereure, S. Dalac, Caroline Dutriaux, M.‐T. Leccia, Délphine Legoupil, Philippe Saïag, F. Brunet‐Possenti, J.-P. Arnnault, E. Maubec, F. Granel‐Brocard, Julie De Quatrebarbes, F. Aubin, Thierry Lesimple, M. Beylot‐Barry, P Stoebner, A. Dupuy, A Stephan, Jean‐Jacques Grob, Wendy Lefevre, Bastien Oriano, Clara Allayous, Célèste Lebbé, Henri Montaudié
Topics & Concepts
MedicineMetastatic melanomaSystemic therapyCohortBody mass indexOncologyRelevance (law)Internal medicineMelanomaCancerCancer researchPolitical scienceLawBreast cancerCutaneous Melanoma Detection and ManagementCancer Risks and FactorsCancer Immunotherapy and Biomarkers